Head-to-head · Cost-Efficiency Index
Breeze Meds vs Oak
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Breeze Meds
People who want to independently verify the clinicians and pharmacy behind their GLP-1 — and who'll pay a mid-market price for that paper trail plus FSA/HSA eligibility.
Visit Breeze MedsOak
Dose-escalators. A flat per-dose price means titrating from 0.25mg to 2.4mg costs the same every month, so the twelve-month number you model on day one is the number you pay.
Visit OakThe verdict
Breeze Meds takes it, leading the Cost-Efficiency Index 86 to 83. The most transparent operator in our partner tier — all-50 compounded GLP-1 with NPI-verifiable named physicians, named pharmacies and LegitScript backing, so you can actually audit who's behind the script. Oak still earns a B — Dose-escalators. A flat per-dose price means titrating from 0.25mg to 2.4mg costs the same every month, so the twelve-month number you model on day one is the number you pay.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the board). See how it stacks up: CoreAge Rx vs Breeze Meds.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Breeze Meds | Oak |
|---|---|---|
| Cost-Efficiency Index | 86/100 | 83/100 |
| Semaglutide / mo | $199/mo | $119/mo (same price at every dose) |
| Tirzepatide / mo | $399/mo | $185/mo (same price at every dose) |
| Semaglutide / yr (modeled) | $2,388 | $1,428 |
| Tirzepatide / yr (modeled) | $4,788 | $2,220 |
| Coverage | All 50 states | 45 states (list not published) |
| Oral / sublingual | Yes | Yes |
| Brand-name access | Compounded only | Compounded only |
| Rank on the board | #5 | #18 |
Breeze Meds
86/100Where the value is
- Best transparency of this partner batch — NPI-verifiable named physicians (Lion MD group), named dispensing pharmacies, and LegitScript certification
- All 50 states, with injectable semaglutide from $199/mo plus oral semaglutide (~$299) and oral tirzepatide (~$399) for the needle-averse
- FSA/HSA eligible, which trims the effective monthly cost
The tradeoffs
- Mid-to-higher per-month pricing — tirzepatide and the oral routes carry a premium over the cheapest all-50 rivals
- Compounded only — not FDA-approved brand-name medication
Oak
83/100Where the value is
- $119 semaglutide and $185 tirzepatide — both among the lowest published on this board, and published before the intake rather than after it
- "ONE PRICE · ALL DOSAGES · NO SUBSCRIPTIONS" — the price does not climb as your dose does, which is where most flat-looking programs quietly get expensive
- A non-injectable route as well as the two weekly injections: sublingual drops or tablets targeting the GLP-1 pathway
The tradeoffs
- It publishes three different prices for the same product: $119 in the homepage hero, $167 in the homepage comparison table and on /product, and $190 in the /weightloss comparison table
- The "$200 OFF — NEW PATIENT OFFER" and "SUMMER SALE — Save up to 60% vs. retail pricing" banners carry no terms, no code and no resulting price anywhere on the site
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.